Postmarketing surveillance of gabapentin

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2002年 / 926卷 / 1期
关键词：
Public Health; Adverse Event; Median Treatment; Adverse Reaction; Gabapentin;
D O I：
10.2165/00128415-200209260-00011
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] POSTMARKETING SURVEILLANCE
    VOSS, S
    HARRIS, F
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 194 - 194
  • [2] POSTMARKETING SURVEILLANCE
    DENES, G
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
  • [3] A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England
    Wilton, LV
    Shakir, S
    [J]. EPILEPSIA, 2002, 43 (09) : 983 - 992
  • [4] POSTMARKETING DRUG SURVEILLANCE
    BORDEN, EK
    GARDNER, JS
    WESTLAND, MM
    GARDNER, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
  • [5] POSTMARKETING SURVEILLANCE OF IUDS
    KESSEL, E
    CHI, IC
    FELDBLUM, P
    [J]. CONTRACEPTIVE DELIVERY SYSTEMS, 1982, 3 (3-4) : 574 - 574
  • [6] CONCERNS WITH POSTMARKETING SURVEILLANCE
    NORVELL, MJ
    ANDERSON, RJ
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (01): : 54 - &
  • [7] Postmarketing surveillance is needed
    Srinivas, VR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 51 - 51
  • [8] POSTMARKETING SURVEILLANCE OF ENALAPRIL
    ROSE, AJ
    [J]. JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1987, 37 (304): : 514 - 514
  • [9] GUIDELINES ON POSTMARKETING SURVEILLANCE
    WELLS, F
    [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6619): : 399 - 400
  • [10] THE DEMISE OF POSTMARKETING SURVEILLANCE
    FLETCHER, AP
    [J]. ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1995, 14 (01): : 7 - 9
12345